Chlorine in PDB 8qfx: Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
Protein crystallography data
The structure of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp, PDB code: 8qfx
was solved by
K.S.Gregory,
K.R.Acharya,
G.E.Cozier,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
79.45 /
1.60
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
74.229,
103.395,
115.416,
84.95,
85.49,
81.55
|
R / Rfree (%)
|
18.1 /
21.1
|
Other elements in 8qfx:
The structure of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
(pdb code 8qfx). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp, PDB code: 8qfx:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 8qfx
Go back to
Chlorine Binding Sites List in 8qfx
Chlorine binding site 1 out
of 4 in the Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl702
b:15.6
occ:1.00
|
OH
|
A:TYR202
|
3.1
|
17.0
|
1.0
|
NE
|
A:ARG500
|
3.1
|
13.6
|
1.0
|
O
|
A:HOH1133
|
3.2
|
14.8
|
1.0
|
NH2
|
A:ARG500
|
3.5
|
13.1
|
1.0
|
CB
|
A:ARG500
|
3.7
|
13.2
|
1.0
|
CB
|
A:PRO497
|
3.8
|
12.7
|
1.0
|
CB
|
A:PRO385
|
3.8
|
14.5
|
1.0
|
CZ
|
A:ARG500
|
3.8
|
14.4
|
1.0
|
CE2
|
A:TYR202
|
3.8
|
14.4
|
1.0
|
N
|
A:ARG500
|
3.8
|
12.0
|
1.0
|
CZ
|
A:TYR202
|
3.9
|
15.9
|
1.0
|
CG2
|
A:ILE499
|
4.0
|
12.4
|
1.0
|
CG
|
A:PRO385
|
4.0
|
13.8
|
1.0
|
CE3
|
A:TRP201
|
4.0
|
19.8
|
1.0
|
CG
|
A:ARG500
|
4.0
|
11.4
|
1.0
|
CZ3
|
A:TRP201
|
4.0
|
20.0
|
1.0
|
CA
|
A:ARG500
|
4.2
|
12.8
|
1.0
|
CD
|
A:ARG500
|
4.2
|
12.6
|
1.0
|
CD
|
A:PRO385
|
4.7
|
13.2
|
1.0
|
C
|
A:PRO497
|
4.7
|
11.7
|
1.0
|
CG
|
A:PRO497
|
4.7
|
13.5
|
1.0
|
C
|
A:ILE499
|
4.8
|
13.6
|
1.0
|
N
|
A:ILE499
|
4.8
|
11.7
|
1.0
|
CA
|
A:PRO497
|
4.9
|
11.9
|
1.0
|
O
|
A:HOH990
|
5.0
|
15.2
|
1.0
|
O
|
A:PRO497
|
5.0
|
11.4
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 8qfx
Go back to
Chlorine Binding Sites List in 8qfx
Chlorine binding site 2 out
of 4 in the Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl702
b:14.3
occ:1.00
|
OH
|
B:TYR202
|
3.1
|
13.7
|
1.0
|
O
|
B:HOH1136
|
3.2
|
15.2
|
1.0
|
NE
|
B:ARG500
|
3.3
|
11.9
|
1.0
|
NH2
|
B:ARG500
|
3.6
|
12.7
|
1.0
|
CB
|
B:PRO385
|
3.6
|
13.5
|
1.0
|
CB
|
B:ARG500
|
3.7
|
11.2
|
1.0
|
N
|
B:ARG500
|
3.7
|
11.2
|
1.0
|
CB
|
B:PRO497
|
3.7
|
11.8
|
1.0
|
CE2
|
B:TYR202
|
3.8
|
14.2
|
1.0
|
CZ
|
B:TYR202
|
3.9
|
15.1
|
1.0
|
CZ
|
B:ARG500
|
3.9
|
12.5
|
1.0
|
CE3
|
B:TRP201
|
3.9
|
16.6
|
1.0
|
CG
|
B:PRO385
|
4.0
|
13.3
|
1.0
|
CG2
|
B:ILE499
|
4.0
|
12.9
|
1.0
|
CZ3
|
B:TRP201
|
4.0
|
15.8
|
1.0
|
CG
|
B:ARG500
|
4.0
|
10.3
|
1.0
|
CA
|
B:ARG500
|
4.1
|
11.1
|
1.0
|
CD
|
B:ARG500
|
4.3
|
11.6
|
1.0
|
CG
|
B:PRO497
|
4.7
|
12.6
|
1.0
|
N
|
B:ILE499
|
4.7
|
10.3
|
1.0
|
CD
|
B:PRO385
|
4.7
|
13.6
|
1.0
|
C
|
B:ILE499
|
4.7
|
11.4
|
1.0
|
C
|
B:PRO497
|
4.8
|
12.2
|
1.0
|
CA
|
B:PRO497
|
4.9
|
11.0
|
1.0
|
O
|
B:HOH1037
|
5.0
|
15.2
|
1.0
|
|
Chlorine binding site 3 out
of 4 in 8qfx
Go back to
Chlorine Binding Sites List in 8qfx
Chlorine binding site 3 out
of 4 in the Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl703
b:14.6
occ:1.00
|
O
|
C:HOH1177
|
3.1
|
15.9
|
1.0
|
OH
|
C:TYR202
|
3.1
|
14.1
|
1.0
|
NE
|
C:ARG500
|
3.2
|
11.4
|
1.0
|
NH2
|
C:ARG500
|
3.6
|
11.8
|
1.0
|
CB
|
C:ARG500
|
3.7
|
12.1
|
1.0
|
CE2
|
C:TYR202
|
3.8
|
13.7
|
1.0
|
CB
|
C:PRO497
|
3.8
|
10.9
|
1.0
|
N
|
C:ARG500
|
3.8
|
12.3
|
1.0
|
CB
|
C:PRO385
|
3.8
|
14.2
|
1.0
|
CZ
|
C:ARG500
|
3.8
|
11.9
|
1.0
|
CZ
|
C:TYR202
|
3.9
|
15.7
|
1.0
|
CG
|
C:PRO385
|
4.0
|
14.5
|
1.0
|
CG2
|
C:ILE499
|
4.0
|
12.8
|
1.0
|
CE3
|
C:TRP201
|
4.0
|
17.4
|
1.0
|
CZ3
|
C:TRP201
|
4.0
|
16.4
|
1.0
|
CG
|
C:ARG500
|
4.1
|
11.0
|
1.0
|
CA
|
C:ARG500
|
4.2
|
12.4
|
1.0
|
CD
|
C:ARG500
|
4.3
|
11.9
|
1.0
|
CG
|
C:PRO497
|
4.7
|
11.4
|
1.0
|
N
|
C:ILE499
|
4.8
|
11.3
|
1.0
|
CD
|
C:PRO385
|
4.8
|
14.9
|
1.0
|
C
|
C:ILE499
|
4.8
|
12.3
|
1.0
|
C
|
C:PRO497
|
4.9
|
11.9
|
1.0
|
O
|
C:HOH1080
|
4.9
|
13.6
|
1.0
|
CA
|
C:PRO497
|
4.9
|
11.4
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 8qfx
Go back to
Chlorine Binding Sites List in 8qfx
Chlorine binding site 4 out
of 4 in the Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Human Angiotensin-1 Converting Enzyme N-Domain in Complex with the Lactotripeptide Ipp within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl703
b:16.1
occ:1.00
|
OH
|
D:TYR202
|
3.1
|
15.8
|
1.0
|
O
|
D:HOH1173
|
3.2
|
15.9
|
1.0
|
NE
|
D:ARG500
|
3.2
|
13.2
|
1.0
|
CB
|
D:ARG500
|
3.6
|
15.6
|
1.0
|
NH2
|
D:ARG500
|
3.6
|
14.9
|
1.0
|
N
|
D:ARG500
|
3.7
|
16.5
|
1.0
|
CB
|
D:PRO385
|
3.7
|
16.0
|
1.0
|
CB
|
D:PRO497
|
3.7
|
13.2
|
1.0
|
CE1
|
D:TYR202
|
3.8
|
16.4
|
1.0
|
CZ
|
D:TYR202
|
3.9
|
17.3
|
1.0
|
CZ
|
D:ARG500
|
3.9
|
13.7
|
1.0
|
CG2
|
D:ILE499
|
3.9
|
14.2
|
1.0
|
CG
|
D:PRO385
|
4.0
|
16.9
|
1.0
|
CE3
|
D:TRP201
|
4.0
|
17.6
|
1.0
|
CZ3
|
D:TRP201
|
4.0
|
19.4
|
1.0
|
CG
|
D:ARG500
|
4.1
|
14.0
|
1.0
|
CA
|
D:ARG500
|
4.1
|
16.3
|
1.0
|
CD
|
D:ARG500
|
4.2
|
14.1
|
1.0
|
CG
|
D:PRO497
|
4.6
|
14.2
|
1.0
|
C
|
D:ILE499
|
4.7
|
15.6
|
1.0
|
N
|
D:ILE499
|
4.7
|
13.7
|
1.0
|
CD
|
D:PRO385
|
4.8
|
17.3
|
1.0
|
C
|
D:PRO497
|
4.8
|
15.1
|
1.0
|
O
|
D:HOH979
|
4.8
|
16.4
|
1.0
|
CA
|
D:PRO497
|
4.9
|
13.6
|
1.0
|
|
Reference:
K.S.Gregory,
G.E.Cozier,
S.L.U.Schwager,
E.D.Sturrock,
K.R.Acharya.
Structural Insights Into the Inhibitory Mechanism of Angiotensin-I-Converting Enzyme By the Lactotripeptides Ipp and Vpp. Febs Lett. 2023.
ISSN: ISSN 0014-5793
PubMed: 37904282
DOI: 10.1002/1873-3468.14768
Page generated: Tue Jul 30 11:58:30 2024
|